SIGA Technologies, Inc.

SIGA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $155.0M $155.4M $150.1M $98.8M $103.1M $117.9M $65.2M $100.7M
Accounts Receivable $3.3M $21.2M $21.1M $45.4M $83.7M $3.3M $4.2M $2.0M
Inventory $49.1M $49.6M $64.2M $39.3M $19.5M $20.3M $9.7M $2.9M
Total Current Assets $212.9M $231.0M $239.0M $185.8M $208.8M $143.6M $180.0M $121.3M
Property, Plant & Equipment $1.1M $1.3M $1.3M $1.8M $2.4M $2.1M $2.6M $171.3K
Goodwill $898.3K $898.3K $898.3K $898.3K $898.3K $898.3K $898.3K $898.3K
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $219.5M $244.3M $254.4M $195.0M $214.7M $149.8M $198.6M $203.4M
Liabilities
Accounts Payable $824.5K $1.3M $1.5M $3.4M $2.0M $1.3M $3.1M $1.7M
Total Current Liabilities $18.0M $25.3M $54.1M $21.5M $30.5M $10.5M $91.7M $11.3M
Long-Term Debt — — — — — — — —
Total Liabilities $20.6M $28.5M $57.5M $24.9M $40.4M $20.0M $100.8M $100.5M
Stockholders' Equity
Retained Earnings $-43.1M $-22.8M $-38.9M $-63.8M $-51.8M $-95.2M $-123.0M $-115.8M
Total Stockholders' Equity $198.8M $215.8M $196.9M $170.2M $174.3M $129.8M $97.8M $102.9M
← Newer Page 1 of 2 Older →